Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Revenue | 39.64 | 30.99 | 60.52 | 52.03 |
Total Revenue | 39.64 | 30.99 | 60.52 | 52.03 |
Costof Revenue Total | 40.97 | 35.22 | 52.67 | 42.30 |
Gross Profit | -1.32 | -4.23 | 7.85 | 9.73 |
Selling/ General/ Admin Expenses Total | 5.99 | 1.24 | 4.60 | 4.21 |
Depreciation/ Amortization | 2.66 | 2.05 | 1.59 | 1.20 |
Unusual Expense( Income) | -0.04 | 0.73 | -0.55 | -2.19 |
Total Operating Expense | 49.58 | 39.25 | 58.32 | 45.52 |
Operating Income | -9.94 | -8.26 | 2.21 | 6.51 |
Interest Inc( Exp) Net- Non- Op Total | -15.94 | -14.70 | -9.15 | -17.75 |
Other Net | -2.34 | -1.65 | -1.78 | -1.59 |
Net Income Before Taxes | -13.87 | -11.37 | -0.49 | 3.14 |
Provisionfor Income Taxes | -10.39 | 0.20 | 0.12 | 0.21 |
Net Income After Taxes | -3.48 | -11.57 | -0.61 | 2.93 |
Net Income Before Extra Items | -3.48 | -11.57 | -0.61 | 2.93 |
Net Income | -3.48 | -11.57 | -0.61 | 2.93 |
Income Availableto Com Excl Extra Ord | -3.48 | -11.57 | -0.61 | 2.93 |
Income Availableto Com Incl Extra Ord | -3.48 | -11.57 | -0.61 | 2.93 |
Diluted Net Income | -3.48 | -11.57 | -0.61 | 2.93 |
Diluted Weighted Average Shares | 3.19 | 1.42 | 1.27 | 1.02 |
Diluted EPS Excluding Extra Ord Items | -1.09 | -8.15 | -0.48 | 2.87 |
Diluted Normalized EPS | -1.10 | -7.81 | -0.76 | 0.87 |
Total Adjustmentsto Net Income | - | 0.00 | - | - |
Other Operating Expenses Total | - | - | 0.00 | 0.00 |
Oxygenta Pharmaceutical Dividend Oxygenta Pharmaceutical Bonus Oxygenta Pharmaceutical News Oxygenta Pharmaceutical AGM Oxygenta Pharmaceutical Rights Oxygenta Pharmaceutical Splits Oxygenta Pharmaceutical Board Meetings Oxygenta Pharmaceutical Key Metrics Oxygenta Pharmaceutical Shareholdings Oxygenta Pharmaceutical Balance Sheet Oxygenta Pharmaceutical Cashflow Oxygenta Pharmaceutical Q1 Results Oxygenta Pharmaceutical Q2 Results Oxygenta Pharmaceutical Q3 Results Oxygenta Pharmaceutical Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks